Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Perol

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 27, 2006
Cost-minimization analysis of a phase III trial comparing concurrent versus sequential radiochemotherapy for locally advanced non-small-cell lung cancer (GFPC-GLOT 95-01)A Vergnenegre, C Combescure, P Fournel, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 1996
The limits of chemotherapy dose intensification using granulocyte colony stimulating factor alone in extensive small cell lung cancerV Trillet-Lenoir, P Soler, D Arpin, et al.
Revue Des Maladies Respiratoires|June 7, 2008
[Idiopathic constrictive péricarditis revealed by a massive left pleural effusion]G Tsémo Watchueng, E De La Roche, S Duperret, et al.
Bulletin Du Cancer|January 1, 1992
[Comparison of 2 cisplatin and etoposide dosages in relapsing small cell lung cancer]V Trillet-Lenoir, C Lasset, D Arpin, et al.
Revue Des Maladies Respiratoires|January 1, 1993
[Clinical and economic evaluation of the initial assessment of small cell cancer of the lung. Alternatives to classic evaluation. LGTO. The Lyon Group of Thoracic Oncology]F Chauvin, P J Souquet, V Trillet-Lenoir, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 1993
Limited disease small cell lung cancer: alternating combination of doxorubicin, etoposide, ifosfamide and hyperfractionated radiotherapy. Final results of a multicentric pilot study for the Groupe Lyonnias d'Oncologie Thoracique (GLOT)V Trillet-Lenoir, F Mornex, F Chauvin, et al.
Revue Des Maladies Respiratoires|January 1, 1993
[Combination of cisplatin-mitomycin-vindesine for inoperable, non-small-cell bronchial cancers. French study group in pneumo-cancerology]J P Kleisbauer, P Thomas, M Perol, et al.
Revue De Pneumologie Clinique|January 1, 1996
[Rare etiology of multiple pulmonary lacunae]K Nourdine, P Nesme, M Perol, et al.
Revue Des Maladies Respiratoires|March 16, 2005
[A rare case of thoracoabdominal opacity]A S Blanchet, C Depagne, P Nesme, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Cisplatin-mitomycin and vindesine in the treatment of inoperable non-small cell lung cancer groupe français de pneumo-cancérologie (GFPC)P Thomas, J P Kleisbauer, M Perol, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 27, 2006
Cost-minimization analysis of a phase III trial comparing concurrent versus sequential radiochemotherapy for locally advanced non-small-cell lung cancer (GFPC-GLOT 95-01)A Vergnenegre, C Combescure, P Fournel, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 1996
The limits of chemotherapy dose intensification using granulocyte colony stimulating factor alone in extensive small cell lung cancerV Trillet-Lenoir, P Soler, D Arpin, et al.
Revue Des Maladies Respiratoires|June 7, 2008
[Idiopathic constrictive péricarditis revealed by a massive left pleural effusion]G Tsémo Watchueng, E De La Roche, S Duperret, et al.
Bulletin Du Cancer|January 1, 1992
[Comparison of 2 cisplatin and etoposide dosages in relapsing small cell lung cancer]V Trillet-Lenoir, C Lasset, D Arpin, et al.
Revue Des Maladies Respiratoires|January 1, 1993
[Clinical and economic evaluation of the initial assessment of small cell cancer of the lung. Alternatives to classic evaluation. LGTO. The Lyon Group of Thoracic Oncology]F Chauvin, P J Souquet, V Trillet-Lenoir, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 1993
Limited disease small cell lung cancer: alternating combination of doxorubicin, etoposide, ifosfamide and hyperfractionated radiotherapy. Final results of a multicentric pilot study for the Groupe Lyonnias d'Oncologie Thoracique (GLOT)V Trillet-Lenoir, F Mornex, F Chauvin, et al.
Revue Des Maladies Respiratoires|January 1, 1993
[Combination of cisplatin-mitomycin-vindesine for inoperable, non-small-cell bronchial cancers. French study group in pneumo-cancerology]J P Kleisbauer, P Thomas, M Perol, et al.
Revue De Pneumologie Clinique|January 1, 1996
[Rare etiology of multiple pulmonary lacunae]K Nourdine, P Nesme, M Perol, et al.
Revue Des Maladies Respiratoires|March 16, 2005
[A rare case of thoracoabdominal opacity]A S Blanchet, C Depagne, P Nesme, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Cisplatin-mitomycin and vindesine in the treatment of inoperable non-small cell lung cancer groupe français de pneumo-cancérologie (GFPC)P Thomas, J P Kleisbauer, M Perol, et al.
Pageof 6